Free Stock Cash Tips and more click here and SUBSCRIBE US FREE >> http://www.ripplesadvisory.com/free-trial.php
Shares of Dr. Reddy's Laboratories advanced nearly 3 per cent on the Bombay stock Exchange after the drug maker said that its API manufacturing plant at Miryalaguda has receives Establishment Inspection Report (EIR) from USFDA on successful closure of Audit. Boosted by the development, shares of the pharma major gained as much as 2.65 per cent to hit intra-day high of Rs 2698.00 apiece on the Bombay Stock Exchange.
The scrip was currently trading at Rs 2683.50 against previous close price of Rs 2628.10. In a similar fashion, stocks of company were trading 2.22 per cent higher at Rs 2,685.00 apiece on the National Stock Exchange. Meanwhile, the broader benchmark BSE Sensex was trading at 31,057.80, down 45.69 points or 0.15 per cent, at 11:35 hours.
No comments:
Post a Comment